Website logo
Home

Blog

For some men, MPOX remains a moderate health risk.

For some men, MPOX remains a moderate health risk.

The World Health Organization (WHO) recently published the 59 multi-country MPOX outbreak situation, providing details of the global epidemiological situation for MPOX.Until November 2, 2025, viruses expressing all variants of monkeypox virus (MPXV) will continue to circulate in all regions.As...

For some men MPOX remains a moderate health risk

The World Health Organization (WHO) recently published the 59 multi-country MPOX outbreak situation, providing details of the global epidemiological situation for MPOX.Until November 2, 2025, viruses expressing all variants of monkeypox virus (MPXV) will continue to circulate in all regions.As of September 2025, 42 countries reported a total of 3,135 confirmed cases, including 12 related deaths.

MPOX is a moderate health risk for some men

World Organization World Organization (WHO) The 59th report of the 59th global edition of MPAX was recently published, describing the Eddidemiological Ranger Rax in detail.

As of November 2, 2025, the World Health Organization reports that all positive monkeypox virus (MPXV) is circulating in all regions.

As of September 2025, 42 countries have reported 3,135 confirmed cases, including 12 associated deaths.

More than 80% of these cases were in the African region.

"Given the community transmission of clade Ib MPXV and its detection among men who have sex with men, WHO currently assesses the public health risk in settings outside of historically endemic areas as moderate for men who have sex with men and low for the general population," WHO wrote.

From a prevention point of view, more than 684,000 doses of MVA-BN (Jynneos) and 118,000 doses of LC16 have been administered in the Democratic Republic of Congo, which accounts for more than 61% of the vaccinated population in African countries.

A national police vaccination plan for MVpox has recently been developed

Additional doses have been provided and sold, and the communities continue to work together to ensure access to minimum vaccination plans and provide immediate funding to implement reacx vaccination plans.

In the United States, the JYNNEOS vaccine is offered at various clinics and pharmacies and is recommended for high-risk individuals.

Our Trusted Practice: Physicians Committee on Medicine

© 2025 Cosmo Sonic, Inc. All Rights Reserved.